These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of hyperlipidemia with a new drug, tibric acid]. Carmena R; González R Florez J; Sanchis J Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065 [No Abstract] [Full Text] [Related]
4. [The clinical pharmacology and efficacy of statins]. Sidorenko BA; Preobrazhenskiĭ DV; Sopoleva IuV Ter Arkh; 1996; 68(9):80-4. PubMed ID: 9005624 [No Abstract] [Full Text] [Related]
5. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)]. Potì R; Quintavalla R; Manotti C G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442 [No Abstract] [Full Text] [Related]
6. Management of hyperlipidemia: an update. Keller KB; Lemberg L Heart Lung; 1990 May; 19(3):317-20. PubMed ID: 2341269 [No Abstract] [Full Text] [Related]
7. Three new drugs for hyperlipidemia. Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842 [No Abstract] [Full Text] [Related]
8. Drug therapy for hyperlipidemia. Am Pharm; 1988 Mar; NS28(3):91-5. PubMed ID: 3285656 [No Abstract] [Full Text] [Related]
9. [Therapeutic effects of bezafibrate in hyperlipidemia]. Kunesová M; Honková M; Zeman M; Mares P; Skorepa J Cas Lek Cesk; 1983 May; 122(20):628-31. PubMed ID: 6342789 [No Abstract] [Full Text] [Related]
10. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185]. Wolfram G; Keller C; Kilani C; Zöllner N Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609 [No Abstract] [Full Text] [Related]
11. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia]. Rouffy J; Loeper J Therapie; 1972; 27(3):433-44. PubMed ID: 4570211 [No Abstract] [Full Text] [Related]
12. Drug evaluation: The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia. Burnett JR IDrugs; 2006 Jul; 9(7):495-9. PubMed ID: 16821163 [TBL] [Abstract][Full Text] [Related]
13. [Acipimox treatment of hyperlipidemia type II]. Noseda G; Fragiacomo C; Cairoli R Schweiz Med Wochenschr; 1982 Dec; 112(49):1790-1. PubMed ID: 6758114 [TBL] [Abstract][Full Text] [Related]
14. Managing dyslipidemia in adults with diabetes. Haffner SM Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130 [No Abstract] [Full Text] [Related]
16. [New developments in the prevention and treatment of atherosclerosis, ischemic heart disease, hyperlipidemia and other diseases]. Samsonov MA; Isaev VA Vopr Pitan; 1995; (4):33-4. PubMed ID: 7483479 [No Abstract] [Full Text] [Related]
17. [Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia]. Janka HU; Standl A; Holler HD; Mehnert H MMW Munch Med Wochenschr; 1982 May; 124(21):535-7. PubMed ID: 6810123 [No Abstract] [Full Text] [Related]
18. Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate. Torossian F; Laredo C Monogr Atheroscler; 1986; 14():222-9. PubMed ID: 3526130 [No Abstract] [Full Text] [Related]